Toru Yamakawa
Toru Yamakawa publishes mostly in Surgery, Hematology and Cancer Research, on topics such as Protease and Inhibitor Mechanisms, Blood Coagulation and Thrombosis Mechanisms and Orthopedic Infections and Treatments.
- World rank
- #3,225,334 of 7,710,434 ranked researchers
- Rank in Japan
- #75,226 of 383,136
- Works
- 17
- Citations
- 417
- Citations per work
- 24.5
What does Toru Yamakawa research?
Toru Yamakawa's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences846.9%
- Medicine846.9%
- Everything else738.8%
- Life Sciences214.3%
- 1Surgery22% of their works
- 2Hematology10% of their works
- 3Cancer Research8% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Pediatrics, Perinatology and Child Health6% of their works
- 6Molecular Biology6% of their works
Research topics
- Protease and Inhibitor Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Orthopedic Infections and Treatments
- Neonatal Respiratory Health Research
- Orthopaedic implants and arthroplasty
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Venous Thromboembolism Diagnosis and Management
- Bone health and osteoporosis research
Which keywords describe Toru Yamakawa's research?
The keywords of their largest research topics: Antithrombotic Therapy, Matrix Metalloproteinases, Periprosthetic Joint Infection, Prosthetic Joint Infections, Protease-Activated Receptors, Thrombin, Tissue Inhibitors of Metalloproteinases and Bronchopulmonary Dysplasia.
- Pulmonary Embolism
- Hereditary Angioedema
- Bone Mineral Density
- Preterm Infants
- Bronchopulmonary Dysplasia
- Thrombin
- Prosthetic Joint Infections
- Matrix Metalloproteinases
- Antithrombotic Therapy
- Periprosthetic Joint Infection
- Protease-Activated Receptors
- Tissue Inhibitors of Metalloproteinases
- Hip Arthroplasty
- Total Hip Replacement
- Fractures
- Kinin Receptor Family
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antithrombotic Therapy62 topics
- Matrix Metalloproteinases41 topic
- Periprosthetic Joint Infection41 topic
- Prosthetic Joint Infections41 topic
- Protease-Activated Receptors41 topic
- Thrombin41 topic
- Tissue Inhibitors of Metalloproteinases41 topic
- Bronchopulmonary Dysplasia31 topic
- Hip Arthroplasty31 topic
- Preterm Infants31 topic
- Total Hip Replacement31 topic
- Bone Mineral Density21 topic
- Fractures21 topic
- Hereditary Angioedema21 topic
- Kinin Receptor Family21 topic
- Pulmonary Embolism21 topic
- Venous Thromboembolism21 topic
Where does Toru Yamakawa work?
Toru Yamakawa's main affiliation in the publication record is Mochida Pharmaceutical (Japan), Japan.
How many publications and citations does Toru Yamakawa have?
OpenAlex counts 17 works and 417 citations for Toru Yamakawa, an h-index of 10, ranking #3,225,334 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Toru Yamakawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.